P10643 (CO7_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 145.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Complement component C7 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 843 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. C7 serves as a membrane anchor. |
| Subunit structure | Monomer or dimer; as a C5b-7 complex it can also form multimeric rosettes. MAC assembly is initiated by protelytic cleavage of C5 into C5a and C5b. C5b binds sequentially C6, C7, C8 and multiple copies of the pore-forming subunit C9. |
| Subcellular location | |
| Post-translational modification | C7 has 28 disulfide bridges. O- and C-glycosylated. O-glycosylated with core 1 or possibly core 8 glycans. Ref.4 Ref.7 |
| Involvement in disease | Complement component 7 deficiency (C7D) [MIM:610102]: A rare defect of the complement classical pathway associated with susceptibility to severe recurrent infections, predominantly by Neisseria gonorrhoeae or Neisseria meningitidis. |
| Sequence similarities | Belongs to the complement C6/C7/C8/C9 family. Contains 1 EGF-like domain. Contains 1 LDL-receptor class A domain. Contains 1 MACPF domain. Contains 2 Sushi (CCP/SCR) domains. Contains 2 TSP type-1 domains. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Complement alternate pathway Complement pathway Cytolysis Immunity Innate immunity |
| Cellular component | Membrane attack complex Secreted |
| Coding sequence diversity | Polymorphism |
| Disease | Disease mutation |
| Domain | EGF-like domain Repeat Signal Sushi |
| PTM | Disulfide bond Glycoprotein |
| Technical term | 3D-structure Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | complement activation Traceable author statement Ref.1. Source: ProtInc complement activation, alternative pathwayInferred from electronic annotation. Source: UniProtKB-KW complement activation, classical pathwayInferred from electronic annotation. Source: UniProtKB-KW cytolysisInferred from electronic annotation. Source: UniProtKB-KW innate immune responseTraceable author statement. Source: Reactome |
| Cellular_component | extracellular region Traceable author statement. Source: Reactome membrane attack complexTraceable author statement Ref.1. Source: ProtInc |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 22 | 22 | ||||||||||||||||||||||||||||||||||||
| Chain | 23 – 843 | 821 | Complement component C7 | PRO_0000023583 | ||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||
| Domain | 27 – 80 | 54 | TSP type-1 1 | |||||||||||||||||||||||||||||||||||
| Domain | 83 – 121 | 39 | LDL-receptor class A | |||||||||||||||||||||||||||||||||||
| Domain | 124 – 456 | 333 | MACPF | |||||||||||||||||||||||||||||||||||
| Domain | 457 – 487 | 31 | EGF-like | |||||||||||||||||||||||||||||||||||
| Domain | 500 – 549 | 50 | TSP type-1 2 | |||||||||||||||||||||||||||||||||||
| Domain | 569 – 628 | 60 | Sushi 1 | |||||||||||||||||||||||||||||||||||
| Domain | 629 – 690 | 62 | Sushi 2 | |||||||||||||||||||||||||||||||||||
| Region | 545 – 615 | 71 | CCP 1 | |||||||||||||||||||||||||||||||||||
| Region | 616 – 693 | 78 | CCP 2 | |||||||||||||||||||||||||||||||||||
| Region | 695 – 770 | 76 | Factor I module (FIM) 1 | |||||||||||||||||||||||||||||||||||
| Region | 771 – 843 | 73 | Factor I module (FIM) 2 | |||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||
| Glycosylation | 36 | 1 | C-linked (Man) Ref.4 | |||||||||||||||||||||||||||||||||||
| Glycosylation | 202 | 1 | N-linked (GlcNAc...) Ref.5 Ref.6 | |||||||||||||||||||||||||||||||||||
| Glycosylation | 503 | 1 | C-linked (Man); partial Ref.4 | |||||||||||||||||||||||||||||||||||
| Glycosylation | 506 | 1 | C-linked (Man); partial Ref.4 | |||||||||||||||||||||||||||||||||||
| Glycosylation | 509 | 1 | C-linked (Man); partial Ref.4 | |||||||||||||||||||||||||||||||||||
| Glycosylation | 696 | 1 | O-linked (GalNAc...) Ref.7 | |||||||||||||||||||||||||||||||||||
| Glycosylation | 754 | 1 | N-linked (GlcNAc...) Ref.6 | |||||||||||||||||||||||||||||||||||
| Disulfide bond | 85 ↔ 96 | By similarity | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 91 ↔ 109 | By similarity | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 103 ↔ 119 | By similarity | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 128 ↔ 165 | By similarity | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 337 ↔ 353 | Ref.8 | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 571 ↔ 613 | By similarity | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 599 ↔ 626 | By similarity | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 631 ↔ 673 | By similarity | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 659 ↔ 688 | By similarity | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 702 ↔ 713 | Ref.8 | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 715 ↔ 750 | Ref.8 | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 721 ↔ 743 | Ref.8 | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 728 ↔ 763 | Ref.8 | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 773 ↔ 782 | Ref.8 | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 776 ↔ 789 | Ref.8 | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 791 ↔ 825 | Ref.8 | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 797 ↔ 818 | Ref.8 | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 805 ↔ 838 | Ref.8 | ||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||
| Natural variant | 128 | 1 | C → R. Corresponds to variant rs2271708 [ dbSNP | Ensembl ]. | VAR_050480 | ||||||||||||||||||||||||||||||||||
| Natural variant | 220 | 1 | R → Q in C7D. Ref.11 | VAR_012643 | ||||||||||||||||||||||||||||||||||
| Natural variant | 379 | 1 | G → R in C7D. Ref.10 | VAR_012644 | ||||||||||||||||||||||||||||||||||
| Natural variant | 389 | 1 | S → T Polymorphism confirmed at protein level. Ref.3 Ref.12 Corresponds to variant rs1063499 [ dbSNP | Ensembl ]. | VAR_033798 | ||||||||||||||||||||||||||||||||||
| Natural variant | 420 | 1 | K → Q. Corresponds to variant rs3792646 [ dbSNP | Ensembl ]. | VAR_022023 | ||||||||||||||||||||||||||||||||||
| Natural variant | 521 | 1 | R → S in C7D. Ref.9 | VAR_012645 | ||||||||||||||||||||||||||||||||||
| Natural variant | 587 | 1 | T → P Polymorphism confirmed at protein level. Ref.1 Ref.12 Corresponds to variant rs13157656 [ dbSNP | Ensembl ]. | VAR_033799 | ||||||||||||||||||||||||||||||||||
| Natural variant | 682 | 1 | E → Q in C7D. Ref.11 | VAR_012646 | ||||||||||||||||||||||||||||||||||
| Natural variant | 687 | 1 | R → H in C7D. Ref.11 | VAR_012647 | ||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 152 | 1 | R → V in CAA60121. Ref.3 | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 821 – 822 | 2 | GA → AL Ref.3 | |||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 706 – 709 | 4 | ||||||||||||||||||||||||||||||||||||
| Beta strand | 712 – 715 | 4 | ||||||||||||||||||||||||||||||||||||
| Helix | 718 – 720 | 3 | ||||||||||||||||||||||||||||||||||||
| Beta strand | 726 – 731 | 6 | ||||||||||||||||||||||||||||||||||||
| Turn | 732 – 734 | 3 | ||||||||||||||||||||||||||||||||||||
| Beta strand | 737 – 741 | 5 | ||||||||||||||||||||||||||||||||||||
| Helix | 742 – 750 | 9 | ||||||||||||||||||||||||||||||||||||
| Beta strand | 755 – 757 | 3 | ||||||||||||||||||||||||||||||||||||
| Beta strand | 766 – 769 | 4 | ||||||||||||||||||||||||||||||||||||
| Beta strand | 778 – 782 | 5 | ||||||||||||||||||||||||||||||||||||
| Beta strand | 784 – 791 | 8 | ||||||||||||||||||||||||||||||||||||
| Helix | 794 – 796 | 3 | ||||||||||||||||||||||||||||||||||||
| Beta strand | 803 – 808 | 6 | ||||||||||||||||||||||||||||||||||||
| Beta strand | 811 – 816 | 6 | ||||||||||||||||||||||||||||||||||||
| Helix | 817 – 826 | 10 | ||||||||||||||||||||||||||||||||||||
| Beta strand | 831 – 836 | 6 | ||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The structure of human complement component C7 and the C5b-7 complex." Discipio R.G., Chakravari D.N., Mueller-Eberhard H.J., Fey G.H. J. Biol. Chem. 263:549-560(1988) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, VARIANT PRO-587. |
| [2] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: PNS. |
| [3] | "Structure of the human C7 gene and comparison with the C6, C8A, C8B and C9 genes." Hobart M.J., Fernie B.A., DiScipio R.G. J. Immunol. 154:5188-5194(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 3-822, VARIANT THR-389. |
| [4] | "The four terminal components of the complement system are C-mannosylated on multiple tryptophan residues." Hofsteenge J., Blommers M., Hess D., Furmanek A., Miroshnichenko O. J. Biol. Chem. 274:32786-32794(1999) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION AT TRP-36; TRP-503; TRP-506 AND TRP-509. |
| [5] | "Screening for N-glycosylated proteins by liquid chromatography mass spectrometry." Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R. Proteomics 4:454-465(2004) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-202, MASS SPECTROMETRY. Tissue: Plasma. |
| [6] | "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry." Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., Smith R.D. J. Proteome Res. 4:2070-2080(2005) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-202 AND ASN-754, MASS SPECTROMETRY. Tissue: Plasma. |
| [7] | "Human urinary glycoproteomics; attachment site specific analysis of N-and O-linked glycosylations by CID and ECD." Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G. Mol. Cell. Proteomics 0:0-0(2011) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION AT THR-696, STRUCTURE OF CARBOHYDRATES, MASS SPECTROMETRY. |
| [8] | "Solution structure of factor I-like modules from complement C7 reveals a pair of follistatin domains in compact pseudosymmetric arrangement." Phelan M.M., Thai C.-T., Soares D.C., Ogata R.T., Barlow P.N., Bramham J. J. Biol. Chem. 284:19637-19649(2009) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 693-843, DISULFIDE BONDS. |
| [9] | "Molecular bases of combined subtotal deficiencies of C6 and C7: their effects in combination with other C6 and C7 deficiencies." Fernie B.A., Wurzner R., Orren A., Morgan B.P., Potter P.C., Platonov A.E., Vershinina I.V., Shipulin G.A., Lachmann P.J., Hobart M.J. J. Immunol. 157:3648-3657(1996) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT C7D SER-521. |
| [10] | "Molecular bases of C7 deficiency: three different defects." Fernie B.A., Orren A., Sheehan G., Schlesinger M., Hobart M.J. J. Immunol. 159:1019-1026(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT C7D ARG-379. |
| [11] | "Complement C7 deficiency: seven further molecular defects and their associated marker haplotypes." Fernie B.A., Hobart M.J. Hum. Genet. 103:513-519(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS C7D GLN-220; GLN-682 AND HIS-687. |
| [12] | "Quantitative detection of single amino acid polymorphisms by targeted proteomics." Su Z.D., Sun L., Yu D.X., Li R.X., Li H.X., Yu Z.J., Sheng Q.H., Lin X., Zeng R., Wu J.R. J. Mol. Cell Biol. 3:309-315(2011) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS THR-389 AND PRO-587, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Web resources
| C7base C7 mutation db |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | J03507 mRNA. Translation: AAA51861.1. BC063851 mRNA. Translation: AAH63851.1. X86328 X86344 Genomic DNA. Translation: CAA60121.1. | ||||||||||||
| IPI | IPI00296608. | ||||||||||||
| PIR | A27340. | ||||||||||||
| RefSeq | NP_000578.2. NM_000587.2. | ||||||||||||
| UniGene | Hs.78065. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P10643. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | P10643. 1 interaction. | ||||||||||||
| MINT | MINT-7032139. | ||||||||||||
| STRING | 9606.ENSP00000322061. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P10643. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 61252057. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | P10643. | ||||||||||||
| PRIDE | P10643. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000313164; ENSP00000322061; ENSG00000112936. | ||||||||||||
| GeneID | 730. | ||||||||||||
| KEGG | hsa:730. | ||||||||||||
| UCSC | uc003jmh.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 730. | ||||||||||||
| GeneCards | GC05P040909. | ||||||||||||
| HGNC | HGNC:1346. C7. | ||||||||||||
| HPA | HPA001465. | ||||||||||||
| MIM | 217070. gene. 610102. phenotype. | ||||||||||||
| neXtProt | NX_P10643. | ||||||||||||
| Orphanet | 169150. Immunodeficiency due to a late component of complements deficiency. | ||||||||||||
| PharmGKB | PA25941. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG145238. | ||||||||||||
| HOGENOM | HOG000111868. | ||||||||||||
| HOVERGEN | HBG005367. | ||||||||||||
| InParanoid | P10643. | ||||||||||||
| KO | K03996. | ||||||||||||
| OMA | GERFRCF. | ||||||||||||
| OrthoDB | EOG4NS3B1. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_6900. Immune System. | ||||||||||||
Gene expression databases | |||||||||||||
| Bgee | P10643. | ||||||||||||
| CleanEx | HS_C7. | ||||||||||||
| Genevestigator | P10643. | ||||||||||||
| GermOnline | ENSG00000112936. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 4.10.400.10. 1 hit. | ||||||||||||
| InterPro | IPR003884. FacI_MAC. IPR023415. LDLR_class-A_CS. IPR002172. LDrepeatLR_classA_rpt. IPR001862. MAC_perforin. IPR020864. MACPF. IPR020863. MACPF_CS. IPR000436. Sushi_SCR_CCP. IPR000884. Thrombospondin_1_rpt. [Graphical view] | ||||||||||||
| Pfam | PF00057. Ldl_recept_a. 1 hit. PF01823. MACPF. 1 hit. PF00084. Sushi. 2 hits. PF00090. TSP_1. 2 hits. [Graphical view] | ||||||||||||
| PRINTS | PR00764. COMPLEMENTC9. | ||||||||||||
| SMART | SM00032. CCP. 2 hits. SM00057. FIMAC. 2 hits. SM00192. LDLa. 1 hit. SM00457. MACPF. 1 hit. SM00209. TSP1. 2 hits. [Graphical view] | ||||||||||||
| SUPFAM | SSF57535. Complement_control_module. 2 hits. SSF82895. TSP1. 2 hits. | ||||||||||||
| PROSITE | PS00022. EGF_1. 1 hit. PS01186. EGF_2. 1 hit. PS50026. EGF_3. False negative. PS01209. LDLRA_1. 1 hit. PS50068. LDLRA_2. 1 hit. PS00279. MACPF_1. 1 hit. PS51412. MACPF_2. 1 hit. PS50923. SUSHI. 2 hits. PS50092. TSP1. 2 hits. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| ChiTaRS | C7. human. | ||||||||||||
| EvolutionaryTrace | P10643. | ||||||||||||
| GenomeRNAi | 730. | ||||||||||||
| NextBio | 2972. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | CO7_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P10643 Secondary accession number(s): Q6P3T5, Q92489 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
